Product Name:Human RUN and FYVE domain- containing protein 1, RUFY1 ELISA KITPacking:96T
Catalog No.:ELI-18609h
Gene Name:RUFY1
Detect Range:0.156-10 ng/mL
Sensitivity:0.078ng/mL
Target Protein Name:RUN and FYVE domain-containing protein 1(RUFY1
Alternative Name:RUFY1,RUN and FYVE domain-containing protein 1(RUFY1Sample type:serum, plasma, tissue homogenates, cell culture supernates or other biological fluids.
ELISA type:Sandwich ELISA KitProduct Description:Human RUN and FYVE domain- containing protein 1, RUFY1 ELISA KIT allows for the in vitro quantitative determination of RUN and FYVE domain-containing protein 1(RUFY1 concentrations in serum, plasma, tissue homogenates, cell culture supernates or other biological fluids.
ELISA Test Principle:The microtiter plate provided in Human RUN and FYVE domain- containing protein 1, RUFY1 ELISA KIT has been pre-coated with an RUN and FYVE domain-containing protein 1(RUFY1 antibody specific to RUN and FYVE domain-containing protein 1(RUFY1 .Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody preparation specific for RUN and FYVE domain-containing protein 1(RUFY1 and then avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then a TMB substrate solution is added to each well. Only those wells that contain RUN and FYVE domain-containing protein 1(RUFY1, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of a sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450 nm.The concentration of RUN and FYVE domain-containing protein 1(RUFY1 in the samples is then determined by comparing the O.D. of the samples to the standard curve.
NOTE:FOR RESEARCH USE ONLY; NOT FOR THERAPEUTIC OR DIAGNOSTIC APPLICATIONS! PLEASE READ ENTIRE PROCEDURE!
The quality assurance and experimental performance of this biological reagent are rigorously optimized and standardized according to its specific technical pathway: Double Antibody Sandwich Method (双抗体夹心法). This ensures maximum reproducibility across clinical research and scientific workflows.